These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 32346771
1. Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent. Kambayashi R, Hagiwara-Nagasawa M, Ichikawa T, Goto A, Chiba K, Nunoi Y, Izumi-Nakaseko H, Matsumoto A, Takahara A, Sugiyama A. Heart Vessels; 2020 Sep; 35(9):1316-1322. PubMed ID: 32346771 [Abstract] [Full Text] [Related]
3. Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity. Burashnikov A, Barajas-Martinez H, Hu D, Nof E, Blazek J, Antzelevitch C. J Cardiovasc Pharmacol; 2012 Jun; 59(6):539-46. PubMed ID: 22370957 [Abstract] [Full Text] [Related]
5. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Blaauw Y, Gögelein H, Tieleman RG, van Hunnik A, Schotten U, Allessie MA. Circulation; 2004 Sep 28; 110(13):1717-24. PubMed ID: 15364815 [Abstract] [Full Text] [Related]
7. In vivo characterization of anti-atrial fibrillatory potential and pharmacological safety profile of INa,L plus IKr inhibitor ranolazine using the halothane-anesthetized dogs. Nunoi Y, Kambayashi R, Goto A, Hagiwara-Nagasawa M, Chiba K, Izumi-Nakaseko H, Kawai S, Takei Y, Matsumoto A, Watanabe Y, Sugiyama A. Heart Vessels; 2021 Jul 28; 36(7):1088-1097. PubMed ID: 33763729 [Abstract] [Full Text] [Related]
8. Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae. Juhász V, Hornyik T, Benák A, Nagy N, Husti Z, Pap R, Sághy L, Virág L, Varró A, Baczkó I. Can J Physiol Pharmacol; 2018 Jan 28; 96(1):18-25. PubMed ID: 28892643 [Abstract] [Full Text] [Related]
9. Translational Studies on Anti-Atrial Fibrillatory Action of Oseltamivir by its in vivo and in vitro Electropharmacological Analyses. Kambayashi R, Izumi-Nakaseko H, Goto A, Tsurudome K, Ohshiro H, Izumi T, Hagiwara-Nagasawa M, Chiba K, Nishiyama R, Oyama S, Nunoi Y, Takei Y, Matsumoto A, Sugiyama A. Front Pharmacol; 2021 Jan 28; 12():593021. PubMed ID: 33995006 [Abstract] [Full Text] [Related]
11. Characterization of remodeling processes in the atria of atrioventricular block dogs: Utility as an early-stage atrial fibrillation model. Kambayashi R, Goto A, Takahara A, Saito H, Izumi-Nakaseko H, Takei Y, Akie Y, Hori M, Sugiyama A. J Pharmacol Sci; 2024 Sep 28; 156(1):19-29. PubMed ID: 39068031 [Abstract] [Full Text] [Related]
12. Cardiohemodynamic and Arrhythmogenic Effects of the Anti-Atrial Fibrillatory Compound Vanoxerine in Halothane-Anesthetized Dogs. Hagiwara-Nagasawa M, Kambayashi R, Goto A, Nunoi Y, Izumi-Nakaseko H, Takei Y, Matsumoto A, Sugiyama A. Cardiovasc Toxicol; 2021 Mar 28; 21(3):206-215. PubMed ID: 33074476 [Abstract] [Full Text] [Related]
17. In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs. Wang K, Takahara A, Nakamura Y, Aonuma K, Matsumoto M, Sugiyama A. J Pharmacol Sci; 2007 Feb 28; 103(2):207-13. PubMed ID: 17299243 [Abstract] [Full Text] [Related]
18. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation. Liu G, Xue X, Gao C, Huang J, Qi D, Zhang Y, Dong JZ, Ma CS, Yan GX. J Am Heart Assoc; 2017 May 18; 6(5):. PubMed ID: 28522677 [Abstract] [Full Text] [Related]
19. Anti-atrial Fibrillatory Versus Proarrhythmic Potentials of Amiodarone: A New Protocol for Safety Evaluation In Vivo. Matsukura S, Nakamura Y, Cao X, Wada T, Izumi-Nakaseko H, Ando K, Sugiyama A. Cardiovasc Toxicol; 2017 Apr 18; 17(2):157-162. PubMed ID: 27040813 [Abstract] [Full Text] [Related]